You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Details for Patent: 8,293,752


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,293,752 protect, and when does it expire?

Patent 8,293,752 protects OJEMDA and is included in two NDAs.

This patent has thirty-one patent family members in eighteen countries.

Summary for Patent: 8,293,752
Title:Compounds useful as Raf kinase inhibitors
Abstract:The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
Inventor(s):Chen Weirong, Cossrow Jennifer, Franklin Lloyd, Guan Bing, Jones John Howard, Kumaravel Gnanasambandam, Lane Benjamin, Littke Adam, Lugovskoy Alexey, Peng Hairuo, Powell Noel, Raimundo Brian C., Tanaka Hiroko, Vessels Jeffrey, Wynn Thomas, Xin Zhili
Assignee:
Application Number:US12164762
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 8,293,752

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Day One Biopharms OJEMDA tovorafenib FOR SUSPENSION;ORAL 218033-001 Apr 23, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Day One Biopharms OJEMDA tovorafenib TABLET;ORAL 217700-001 Apr 23, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,293,752

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 067354 ⤷  Sign Up
Australia 2008273002 ⤷  Sign Up
Brazil PI0813499 ⤷  Sign Up
Canada 2693182 ⤷  Sign Up
Chile 2008001933 ⤷  Sign Up
China 101784545 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.